J3260 HCPCS Level II code: Injection, tobramycin sulfate, up to 80 mg
J3260 is the HCPCS code for “Injection, tobramycin sulfate, up to 80 mg” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J3260Injection, tobramycin sulfate, up to 80 mg
Short description: Tobramycin sulfate injection
HCPCS · United States
Medicare details
The indicators CMS publishes with J3260 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Special coverage instructions apply
- Medicare pricing
- Drugs
- Type of service
- Medical care; Lump sum purchase of DME, prosthetics, orthotics
- BETOS category
- Other drugs
- Added
- Jan 1, 1982
Where J3260 sits
- 1J codesDrugs administered other than orally
- 2Active code J3260Injection, tobramycin sulfate, up to 80 mg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J3260 mean?
J3260 is the HCPCS code for “Injection, tobramycin sulfate, up to 80 mg” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J3260?
CMS lists J3260’s Medicare coverage as “Special coverage instructions apply” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J3260
All J codesJ3243Injection, tigecycline, 1 mgJ3244Injection, tigecycline (accord), not therapeutically equivalent to j3243, 1 mgJ3245Injection, tildrakizumab, 1 mgJ3246Injection, tirofiban hcl, 0.25 mgJ3247Injection, secukinumab, intravenous, 1 mgJ3250Injection, trimethobenzamide hcl, up to 200 mgJ3262Injection, tocilizumab, 1 mgJ3263Injection, toripalimab-tpzi, 1 mgJ3265Injection, torsemide, 10 mg/mlJ3268Injection, delafloxacin, 1 mgJ3280Injection, thiethylperazine maleate, up to 10 mgJ3285Injection, treprostinil, 1 mg